The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity
- 1 January 2001
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 34 (1) , 140-147
- https://doi.org/10.1016/s0168-8278(00)00026-x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Health-related quality of life in chronic hepatitis C: Impact of disease and treatment responseHepatology, 1999
- Reduction of Health–Related Quality of Life in Chronic Hepatitis C and Improvement With Interferon TherapyHepatology, 1999
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virusPublished by Elsevier ,1998
- Epidemiology of hepatitis CHepatology, 1997
- Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis CThe Lancet, 1997
- A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis CQuality of Life Research, 1997
- Clinical Outcomes after Transfusion-Associated Hepatitis CNew England Journal of Medicine, 1995
- Long-Term Mortality after Transfusion-Associated Non-A, Non-B HepatitisNew England Journal of Medicine, 1992
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992